Astellas Pharma Shares Outstanding 2012-2019 | ALPMY

Astellas Pharma shares outstanding history from 2012 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Astellas Pharma shares outstanding for the quarter ending December 31, 2019 were M, a 100% decline year-over-year.
  • Astellas Pharma 2020 shares outstanding were 1.878B, a 2.91% decline from 2019.
  • Astellas Pharma 2019 shares outstanding were 1.934B, a 4.86% decline from 2018.
  • Astellas Pharma 2018 shares outstanding were 2.032B, a 4.26% decline from 2017.
Astellas Pharma Annual Shares Outstanding
(Millions of Shares)
2020 1,878
2019 1,934
2018 2,032
2017 2,123
2016 2,161
2015 2,212
2014 2,247
2013 2,294
2012 2,340
2011 2,340
2010 2,380
2009 2,520
2008 2,595
2007 2,689
2006 2,819
Astellas Pharma Quarterly Shares Outstanding
(Millions of Shares)
2019-12-31
2019-06-30 1,888
2018-06-30 2,008
2017-06-30 2,066
2016-09-30 2,160
2016-06-30 2,127
2016-03-31 2,161
2015-12-31 2,170
2015-09-30 2,179
2015-06-30 2,190
2015-03-31 2,212
2014-12-31 2,216
2014-09-30 2,217
2014-06-30 2,223
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $29.844B $11.967B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.114B 36.95
Takeda Pharmaceutical (TAK) Japan $54.448B 9.54
Eisai (ESALY) Japan $24.126B 20.91
UCB SA (UCBJF) Belgium $23.749B 0.00
Merck (MKGAF) Germany $16.013B 0.00
Grifols, S.A (GRFS) Spain $12.761B 15.86
Catalent (CTLT) United States $12.084B 46.71
Neurocrine Biosciences (NBIX) United States $12.044B 55.66
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.650B 45.99
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.900B 9.44
United Therapeutics (UTHR) United States $5.169B 9.79
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.530B 494.56
Nektar Therapeutics (NKTR) United States $4.276B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.840B 14.12
FibroGen (FGEN) United States $3.722B 0.00
ChemoCentryx (CCXI) United States $3.693B 0.00
PTC Therapeutics (PTCT) United States $3.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.492B 10.24
Pacira BioSciences (PCRX) United States $2.435B 49.83
Sage Therapeutics (SAGE) United States $2.228B 0.00
Cronos Group (CRON) Canada $2.205B 63.20
Corcept Therapeutics (CORT) United States $1.890B 18.74
Xencor (XNCR) United States $1.817B 0.00
USANA Health Sciences (USNA) United States $1.729B 17.74
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.677B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.571B 12.02
Akebia Therapeutics (AKBA) United States $1.561B 0.00
Indivior (INVVY) United States $1.523B 18.91
Zogenix (ZGNX) United States $1.507B 0.00
Heron Therapeutics (HRTX) United States $1.429B 0.00
Esperion Therapeutics (ESPR) United States $1.410B 0.00
Karyopharm Therapeutics (KPTI) United States $1.402B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.392B 15.00
Theravance Biopharma (TBPH) Cayman Islands $1.364B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.024B 45.70
Tilray (TLRY) Canada $1.000B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.959B 0.00
Endo (ENDP) Ireland $0.790B 1.22
ImmunoGen (IMGN) United States $0.753B 0.00
Aerie Pharmaceuticals (AERI) United States $0.619B 0.00
Radius Health (RDUS) United States $0.618B 0.00
Trillium Therapeutics (TRIL) Canada $0.606B 0.00
VAXART, INC (VXRT) United States $0.592B 0.00
Molecular Templates (MTEM) United States $0.591B 0.00
Collegium Pharmaceutical (COLL) United States $0.574B 0.00
Ardelyx (ARDX) United States $0.571B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.557B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.511B 12.35
Crinetics Pharmaceuticals (CRNX) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.464B 18.11
Flexion Therapeutics (FLXN) United States $0.462B 0.00
Siga Technologies (SIGA) United States $0.462B 0.00
DURECT (DRRX) United States $0.412B 0.00
TherapeuticsMD (TXMD) United States $0.408B 0.00
Harpoon Therapeutics (HARP) United States $0.406B 0.00
Ocular Therapeutix (OCUL) United States $0.396B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.389B 0.00
Organogenesis Holdings (ORGO) United States $0.366B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
MEI Pharma (MEIP) United States $0.352B 0.00
Altimmune (ALT) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.300B 0.00
Concert Pharmaceuticals (CNCE) United States $0.299B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
PROFOUND MEDICL (PROF) Canada $0.288B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.248B 0.00
Taiwan Liposome (TLC) Taiwan $0.241B 0.00
Redhill Biopharma (RDHL) Israel $0.238B 0.00
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Lannett Co Inc (LCI) United States $0.232B 5.08
KalVista Pharmaceuticals (KALV) United States $0.220B 0.00
Rafael Holdings (RFL) United States $0.204B 0.00
Jounce Therapeutics (JNCE) United States $0.201B 4.80
OptiNose (OPTN) United States $0.189B 0.00
Nivalis Therapeutics (ALPN) United States $0.182B 0.00
IMV INC (IMV) Canada $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 23.80
Aquestive Therapeutics (AQST) United States $0.144B 0.00
Otonomy (OTIC) United States $0.130B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.129B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Xeris Pharmaceuticals (XERS) United States $0.099B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.099B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Onconova Therapeutics (ONTX) United States $0.096B 0.00
CTI BioPharma (CTIC) United States $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
Biomerica (BMRA) United States $0.088B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
Heat Biologics (HTBX) United States $0.086B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
PolarityTE (PTE) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.87
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Novan (NOVN) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 86.09
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
GTx (ONCT) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.00
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00